← OPKO HEALTH, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $1.2b |
$1.1b
-12.62%
|
$990.3m
-7.24%
|
$901.9m
-8.92%
|
$1.4b
+59.15%
|
$1.8b
+23.64%
|
$1.0b
-43.42%
|
$863.5m
-14.01%
|
$713.1m
-17.41%
|
$606.9m
-14.90%
|
$587.9m
-3.13%
|
|
| Cost of Revenue | $564.1m |
$61.2m
-89.15%
|
$803.1m
+1212.78%
|
$832.7m
+3.68%
|
$1.0b
+22.75%
|
$1.3b
+25.92%
|
$716.0m
-44.37%
|
$545.4m
-23.83%
|
$494.6m
-9.30%
|
$400.9m
-18.94%
|
$348.2m
-13.15%
|
|
| Gross Profit (derived) | $657.6m |
$1.0b
+53.04%
|
$187.1m
-81.40%
|
$69.3m
-63.00%
|
$413.3m
+496.78%
|
$487.6m
+17.98%
|
$288.2m
-40.89%
|
$318.1m
+10.38%
|
$218.5m
-31.31%
|
$205.9m
-5.75%
|
$239.7m
+16.39%
|
|
| Research and Development Expense | $111.2m | $125.2m | $125.6m | $117.9m | $75.3m | $76.8m | $73.9m | $89.6m | $105.2m | $124.0m | $125.2m | |
| Selling, General and Administrative Expense | $490.9m | $521.0m | $358.3m | $343.3m | $355.6m | $468.9m | $372.7m | $300.6m | $304.2m | $223.0m | $205.8m | |
| Amortization of Intangible Assets | $64.4m | $84.7m | $67.9m | $64.8m | $56.4m | $50.3m | $87.8m | $86.0m | $82.6m | $77.9m | — | |
| Operating Expenses | $1.3b | $1.3b | $1.2b | $1.2b | $1.4b | $1.8b | $1.2b | $1.0b | — | — | $755.8m | |
| Operating Income (Loss) | ($73.3m) |
($280.1m)
-282.21%
|
($171.2m)
+38.87%
|
($274.1m)
-60.08%
|
$57.7m
+121.06%
|
$18.8m
-67.51%
|
($226.3m)
-1306.68%
|
($157.0m)
+30.60%
|
($152.1m)
+3.16%
|
($117.4m)
+22.79%
|
($167.9m)
-43.00%
|
|
| Interest Expense | $7.4m | $6.6m | $11.9m | $21.5m | $21.9m | $18.9m | $12.1m | $13.5m | $47.5m | $0 | $45.0m | |
| Equity Securities, FV-NI, Realized Gain (Loss) | — | — | $2.8m | ($7.4m) | $10.3m | $3.0m | $0 | $0 | ($54.0m) | ($4.3m) | — | |
| Foreign Currency Transaction Gain (Loss), before Tax | $800k | $1.4m | $1.9m | $400k | $1.6m | ($1.4m) | ($1.8m) | $1.2m | ($3.8m) | ($2.0m) | — | |
| Gain (Loss) on Investments | ($7.7m) | ($14.5m) | ($14.5m) | ($2.9m) | ($480k) | ($629k) | ($383k) | ($107k) | ($18k) | ($29k) | — | |
| Gain (Loss) on Derivative Instruments, Net, Pretax | $2.8m | $52k | $3.0m | $174k | $50k | $846k | $649k | ($781k) | ($26.2m) | ($429k) | — | |
| Other Nonoperating Income (Expense) | $3.9m | $10.5m | $1.5m | ($11.3m) | $12.7m | ($14.8m) | ($155.8m) | ($17.0m) | $206.9m | ($29.9m) | — | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | $47.5m | $108.5m | $45.0m | |
| Income (Loss) from Equity Method Investments | ($7.7m) | ($14.5m) | ($14.5m) | ($2.9m) | ($480k) | ($629k) | ($383k) | ($107k) | ($18k) | ($29k) | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | ($92.2m) | ($247.9m) | ($132.1m) | ($236.5m) | $81.7m | ($3.0m) | ($389.4m) | ($198.4m) | $45.8m | ($188.5b) | ($79.8m) | |
| Current Income Tax Expense (Benefit) | $5.4m | $2.8m | ($3.6m) | $2.7m | $2.0m | $5.3m | $10.9m | $4.3m | $28.1m | ($714k) | ($7.0m) | |
| Income Tax Expense (Benefit) | ($56.1m) | $18.9m | ($38.7m) | $7.1m | $17.6m | $15.5m | ($63.5m) | $4.4m | $42.8m | ($15.7m) | ($7.0m) | |
| Net Income (Loss) Attributable to Parent | ($25.1m) |
($308.9m)
-1131.39%
|
($153.0m)
+50.45%
|
($314.9m)
-105.78%
|
$30.6m
+109.71%
|
($30.1m)
-198.55%
|
($328.4m)
-989.49%
|
($188.9m)
+42.49%
|
($53.2m)
+71.82%
|
($225.7m)
-324.02%
|
($72.9m)
+67.70%
|
|
| Net Income (Loss) Attributable to Noncontrolling Interest | $0 | $0 | — | — | — | — | — | — | — | — | ($72.9m) | |
| Earnings Per Share, Basic | ($0.05) | ($0.55) | ($0.27) | ($0.53) | $0.05 | ($0.05) | ($0.46) | ($0.25) | ($0.08) | ($0.30) | ($0.07) | |
| Earnings Per Share, Diluted | ($0.10) | ($0.55) | ($0.27) | ($0.53) | $0.05 | ($0.05) | ($0.46) | ($0.25) | ($0.08) | ($0.30) | ($0.07) | |
| Weighted Average Number of Shares Outstanding, Basic | 550.8m | 559.2m | 563.1m | 595.5m | 640.7m | 648.1m | 719.1m | 751.8m | 694.0m | 751.1m | 779.3m | |
| Weighted Average Number of Shares Outstanding, Diluted | 555.6m | 559.2m | 563.1m | 595.5m | 640.7m | 648.1m | 719.1m | 751.8m | 694.0m | 751.1m | 779.3m | |
| Additional Financial Items | ||||||||||||
| Costs and Expenses | — | — | — | — | — | — | — | — | $865.2m | $724.3m | — | |
| Goodwill, Impairment Loss | — | — | $11.7m | $26.2m | $0 | $0 | — | — | — | $0 | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.